XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue:    
Total net revenues $ 99,673 $ 56,540
Operating expenses:    
Product cost of sales (excludes amortization of intangible assets) 43,534 18,299
Settlement payment from daewoong (25,500) 0
Selling, general and administrative 112,068 98,190
Research and development 2,064 1,722
Revaluation of contingent royalty obligation to Evolus Founders 6,290 (2,007)
Depreciation and amortization 5,622 7,027
Litigation settlement expenses 0 83,421
Restructuring costs 0 2,956
Total operating expenses 144,078 209,608
Loss from operations (44,405) (153,068)
Other income (expense):    
Interest income 1 635
Interest expense (1,396) (10,503)
Loss from extinguishment of debts, net (968) 0
Loss before income taxes (46,768) (162,936)
Income tax expense 42 77
Net loss (46,810) (163,013)
Other comprehensive gain:    
Unrealized loss on available-for-sale securities, net of tax 0 (6)
Comprehensive loss $ (46,810) $ (163,019)
Net loss per share, basic (in dollars per share) $ (0.94) $ (4.83)
Net loss per share, diluted (in dollars per share) $ (0.94) $ (4.83)
Weighted-average shares outstanding used to compute basic net loss per share (in shares) 49,773,101 33,737,838
Weighted-average shares outstanding used to compute diluted net loss per share (in shares) 49,773,101 33,737,838
Cost, Product and Service [Extensible Enumeration] Product revenue, net Product revenue, net
Product revenue, net    
Revenue:    
Total net revenues $ 98,971 $ 55,802
Service revenue    
Revenue:    
Total net revenues $ 702 $ 738